1 domain / 2 areas / 1 specialization
Morgan Stanley
Data updated
Morgan Stanley is a global financial services firm and institutional investor founded in 1935. Public Morgan Stanley pages describe the firm as headquartered in New York, with worldwide offices and clients across institutions, corporations, governments, and individuals.
In the psychedelic ecosystem, Morgan Stanley’s relevance is mostly indirect: its investment management arm covers global public and private markets, and its published research has discussed psychedelics as an emerging theme in healthcare and investing. The firm does not present a public psychedelic investment focus, but its broad capital-markets and growth-investing platform could make it relevant to late-stage life sciences and adjacent healthcare companies.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
Morgan Stanley is a large, multi-strategy financial institution with institutional investment capabilities spanning public equities, private markets, credit, alternatives, and customized solutions for global clients. Its public materials emphasize long-term performance, global reach, and diversified strategies rather than a dedicated psychedelic thesis, though Morgan Stanley research has covered psychedelics as an emerging healthcare and market topic.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1935
- HQ
- New York, NY 10036 (World Headquarters), United States
- Website
- Visit